Delivery Order SPE2DB22D2214-SPE2DB24FS3EF

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The $4,234.72 firm fixed-price delivery order was awarded on November 8, 2021, with a completion date of November 9, 2021. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,479.42, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $10,554.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a performance period ending on February 28, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award did not have any set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,159.86 Firm Fixed Price Delivery Order contract provides for the supply of 4566188072 NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The award has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,240.97 Firm Fixed Price Delivery Order contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The award, valued at $5,183.25, is a delivery order contract with a firm fixed price. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award, valued at $9,092.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,937.02, is for the delivery of 4564617016 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 16, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 4564003081 - NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a ceiling value of $4,375.09. The contract is a firm fixed price delivery order with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp has...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS3EF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,399.00 firm-fixed-price delivery order is for the supply of 4563311186 NITROFURANTOIN 25 MG/5 ML SUSP 240ML, with a completion date of January 12, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, as well as a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs enable the company to efficiently provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/13/25, 10:04 AM